Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines.docVIP

Viruses 2012, 4, 2711-2735; doi:10.3390/v4112711 OPEN ACCESS viruses ISSN 1999-4915 /journal/viruses Review Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines Jianfeng Zhang Vaxin Inc, 19 Firstfield Road, Suite 200, Gaithersburg, Maryland 20878, USA; E-Mail: zhang@; Tel.: +1-240-654-1450 (ext. 12); Fax: +1-855-557-1369. Received: 30 September 2012; in revised form: 22 October 2012 / Accepted: 25 October 2012 / Published: 1 November 2012 Abstract: The emergence of a highly pathogenic avian influenza virus H5N1 has increased the potential for a new